Novel processing techniques of pH and heat stable chitosan nano-particles

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-07-01

著者

• Maeda S

  Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation

• Seto M

  Department Of Hematology And Chemotherapy

• Seto Masao

  東京大学医学部附属病院 無菌治療部

• 斎本 博之

  鳥取大院・工

• 齋本 博之

  鳥取大工学部物質工学科

• Okamura Yasuhiko

  (tottori University) United Graduate School Yamaguchi University

• Miyawaki Shuichi

  Leukemia Research Center Saiseikai Maebashi Hospital

• SANO Masayuki

  Departments of Internal Medicine Saga Medical School

• Sakai Mari

  Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi

• Sato M

  Division Of Molecular Medicine Aichi Cancer Center Research Institute

• Lin Yi-shen

  (tottori University) United Graduate School Yamaguchi University

• Minami S

  Nagasaki Cml Study Group

• Minami S

  (tottori University) United Graduate School Yamaguchi University

• Matsuda Shin

  Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation

• Miyawaki Shuichi

  Saiseikai Maebashi Hospital Maebashi Jpn

• RENBUTSU Eiko

  (Tottori University) United Graduate School, Yamaguchi University

• MORIMOTO Minoru

  Research Center for Bioscience and Technology

• TSUKA Takeshi

  (Tottori University) United Graduate School, Yamaguchi University

• SAIMOTO Hiroyuki

  Department of Chemistry and Biotechnology, Graduate School of Engineering, Tottori University

• OKAMOTO Yoshiharu

  (Tottori University) United Graduate School, Yamaguchi University

• MINAMI Saburo

  (Tottori University) United Graduate School, Yamaguchi University

• Minami Saburo

  (tottori University) United Graduate School Yamaguchi University

• Okamoto Yoshiharu

  (tottori University) United Graduate School Yamaguchi University

• Renbutsu Eiko

  (tottori University) United Graduate School Yamaguchi University

• Moriyama Mitsuaki

  Departnemt Of Veterinary Physiology College Of Agriculture Osaka Prefecture Universtiy

• Oakamto Yoshiharu

  (tottori University) United Graduate School Yamaguchi University

• Moriyama M

  Research Center For Bioscience And Technology

• Moritaka S

  Department Of Surgery Ii Nagoya City University Medical School

• 斉本 博之

  鳥取大院・工

• Saimoto Hiroyuki

  Department Of Chemistry And Biotechnology Graduate School Of Engineering Tottori University

• Mori Sayaka

  Department Of Clinical Laboratory Nagasaki University Hospital

関連論文

• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• 内視鏡検査に用いる新規マーキング材料 : キトサンを用いた生体マーキング材料の開発
• キトサンを用いた生体マーキング材料の開発
• キトサンへのマイケル付加反応による化学修飾
• 紫外線硬化型キトサン誘導体の生体適合性
• Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
• Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
• Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
• Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32
• Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
• Gastric low-grade B-cell MALT lymphoma : treatment, response, and genetic alteration
• Clinicopathologic Comparison between the API2-MALT1 Chimeric Transcriptpositive and -negative Gastric low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
• Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
• Impact of Established Risk Factors for Breast Cancer in Nulligravid Japanese Women
• Expression profiling analysis of the CD5^+ diffuse large B-cell lymphoma subgroup : Development of a CD5 signature
• Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
• Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
• Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
• Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
• Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
• Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
• MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
• CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
• Assessment of Prognostic Factors in Follicular Lymphoma Patients
• Association of p53 Codon Arg72Pro and p73 G4C14-to-A4T14 at Exon 2 Genetic Polymorphisms with the Risk of Japanese Breast Cancer
• Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis : A retrospective study
• Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
• A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
• A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3
• Clinical Aspects of Multimodality Therapy for Resectable Locoregional Esophageal Cancer
• Physical exercise reduces risk of breast cancer in Japanese women
• Transforming Growth Factor B1 T29C Polymorphism and Breast Cancer Risk in Japanese Women
• High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
• A Phase II Study of S-1 in Patients with Metastatic Breast Cancer : A Japanese Trial by the S-1 Cooperative Study Group, Breast Cancer Working Group
• Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
• Early Detection of Plasma Cytomegalovirus DNA by Real-Time PCR after Allogeneic Hematopoietic Stem Cell Transplantation
• Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
• Expression of the TCL1 Gene at 14q32 in B-Cell Malignancies but Not in Adult T-Cell Leukemia
• Novel processing techniques of pH and heat stable chitosan nano-particles
• Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
• Acute myeloid leukemia in the elderly : 159 Nagoya case studies
• Results of patch testing with 1, 3-butylene glycol from 1994 to 1999
• The Positive Nuclear Staining Observed with Monoclonal Antibody against PRAD1/Cyclin D1 Correlates with mRNA Expression in Mantle Cell Lymphoma
• Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
• Latex protein induced delayed-type contact allergy
• A case of contact dermatitis due to water-soluble licorice extract
• A case of contact dermatitis due to glycol salicylate
• The study on the role of Myocoptes musculinus (kekuidani) on the skin eruptions of the atopic model mice (NC mice)
• Effect of zinc oxide ointment containing nonanoic acid vanillylamide (ZONVA) on the skin eruptions of atopic model mice (NC/F mice)
• Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
• Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
• Some components of adipic polyesters induce allergic contact dermatitis
• Study about the stinging sensation due to a tacrolimus ointment on atopic dermatitis patients
• Five cases of latex allergy from 1998 to 2000
• Three cases of lip dermatitis due to diisostearyl malate
• Photocontact dermatitis due to ketoprofen ; possible mechanism of photocontact allergy and the photocross-reactivity to suprofen, tiaprofenic acid
• Di(2-ethylhexyl) phthalate (DOP) in a vinyl-chloride slip-guard of cotton gloves caused contact urticaria syndrome
• Safety evaluation of hypo-irritant products containing 0.005% nonanoic acid vanillylamide (NVA) on the patients with skin diseases
• Clinical evaluation of hypo-irritant products containing 0.005% nonanoic acid vanillylamide (NVA) on the itching sensation of the patients under dialysis
• A questionnaire study on the dialysis patients
• Study on the skin function of dialysis patients
• Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer
• Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population
• LKB1 Gene Alterations in Surgically Resectable Adenocarcinoma of the Lung
• Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Prognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer
• Profile of Participants and Genotype Distributions of 108 Polymorphisms in a Cross-Sectional Study of Associations of Genotypes With Lifestyle and Clinical Factors : A Project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study
• Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
• Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
• A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
• Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
• An Instructive Case Suggesting Warfarin Resistance Which is Independent on the Regulation of the CYP2C9 and VKORC1 Genotype
• Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
• Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
• Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study

もっと見る 閉じる

スポンサーリンク